KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Raw Materials (2016 - 2026)

Zimmer Biomet Holdings has reported Raw Materials over the past 16 years, most recently at $285.5 million for Q1 2026.

  • For Q1 2026, Raw Materials rose 4.85% year-over-year to $285.5 million; the TTM value through Mar 2026 reached $285.5 million, up 4.85%, while the annual FY2025 figure was $273.2 million, 5.3% down from the prior year.
  • Raw Materials for Q1 2026 was $285.5 million at Zimmer Biomet Holdings, up from $273.2 million in the prior quarter.
  • Over five years, Raw Materials peaked at $314.8 million in Q1 2024 and troughed at $223.4 million in Q2 2022.
  • A 5-year average of $278.3 million and a median of $285.5 million in 2026 define the central range for Raw Materials.
  • Biggest five-year swings in Raw Materials: fell 20.07% in 2022 and later skyrocketed 31.83% in 2023.
  • Year by year, Raw Materials stood at $261.3 million in 2022, then increased by 17.68% to $307.5 million in 2023, then decreased by 6.18% to $288.5 million in 2024, then dropped by 5.3% to $273.2 million in 2025, then grew by 4.5% to $285.5 million in 2026.
  • Business Quant data shows Raw Materials for ZBH at $285.5 million in Q1 2026, $273.2 million in Q4 2025, and $275.1 million in Q3 2025.